Surmodics | SRDX - Des Atouts



Des Atouts Changement Date
Abbott USD 110.43B 23.72B 2026-03
Align Technology USD 6.42B 103.41M 2026-06
Anika Therapeutics USD 183.47M 4.09M 2026-06
Arrowhead Research USD 2.11B 156.25M 2026-06
Artivion USD 1.07B 188.78M 2026-06
Baxter International USD 19.79B 55M 2026-06
Boston Scientific USD 45.22B 865M 2026-06
EDAP TMS EUR 72.06M 10.6M 2026-03
Edwards Lifesciences USD 13.87B 545.9M 2026-06
Haemonetics USD 2.37B 30.52M 2026-06
Heron Therapeutics USD 252.26M 6.05M 2026-06
J&J USD 201.06B 167M 2026-06
Merit Medical Systems USD 2.86B 144.34M 2026-06
Mesa Laboratories USD 434.85M 4.5M 2025-12
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Option Care Health USD 3.38B 1.32M 2026-06
Stryker USD 47.93B 1.64B 2026-06
Trinity Biotech USD 105.16M 1.45M 2025-12